Kamil Ali-Jackson
2016
In 2016, Kamil Ali-Jackson earned a total compensation of $2.7M as Chief Legal Officer at Aclaris Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $128,800 |
---|---|
Option Awards | $1,863,680 |
Salary | $320,000 |
Stock Awards | $401,005 |
Other | $11,717 |
Total | $2,725,202 |
Ali-Jackson received $1.9M in option awards, accounting for 68% of the total pay in 2016.
Ali-Jackson also received $128.8K in non-equity incentive plan, $320K in salary, $401K in stock awards and $11.7K in other compensation.
Rankings
In 2016, Kamil Ali-Jackson's compensation ranked 3,571st out of 14,075 executives tracked by ExecPay. In other words, Ali-Jackson earned more than 74.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,571 out of 14,075 | 75th |
Division Manufacturing | 1,242 out of 5,489 | 77th |
Major group Chemicals And Allied Products | 376 out of 1,895 | 80th |
Industry group Drugs | 273 out of 1,538 | 82nd |
Industry Pharmaceutical Preparations | 216 out of 1,176 | 82nd |
Source: SEC filing on April 21, 2017.
Ali-Jackson's colleagues
We found two more compensation records of executives who worked with Kamil Ali-Jackson at Aclaris Therapeutics in 2016.